HALO logo
halo search icon
Atea Pharmaceuticals, Inc.

US$4.19

Price Change Indicator
0.04 (0.964%)
Atea Pharmaceuticals, Inc.
AVIR · NAS

Atea Pharmaceuticals, Inc.

Start Trading AVIR for Free

US$4.19

Price Arrow0.04 (0.964%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueNear SupportRecent Price downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Atea Pharmaceuticals, Inc. Overview

AVIR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AVIR

icon
icon

Telephone

1.857.284.8891

icon

Address

Suite 2100, 225 Franklin Street, Boston, MA 02110

Description

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

AVIR Price Chart

Key Stats

Market Cap

US$332.11M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.78 - 6.45

Trade Value (12mth)

US$413,313.00

1 week

1.22%

1 month

-24.82%

YTD

19.25%

1 year

47.69%

All time high

94.17

Key Fundamentals

EPS 3 yr Growth

39.50%

EBITDA Margin

0.00%

Operating Cashflow

-$132m

Free Cash Flow Return

-36.90%

ROIC

-44.30%

Interest Coverage

0.00

Quick Ratio

7.80

Other Data

Shares Outstanding (Fully Diluted)

79m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AVIR Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

AVIR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.63-2-1.94locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.63-2-1.94locklocklock
Growth
 %locklocklocklock-17.1-22.62.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Atea Pharmaceuticals, Inc. (AVIR:NAS)?
Halo FAQ
The current share price of Atea Pharmaceuticals, Inc. (AVIR:NAS) is USD$4.19.
What is the 52-week high share price for Atea Pharmaceuticals, Inc. (AVIR:NAS)?
Halo FAQ
The 52-week high share price for Atea Pharmaceuticals, Inc. (AVIR:NAS) is USD$6.45.
What is the 52-week low share price for Atea Pharmaceuticals, Inc. (AVIR:NAS)?
Halo FAQ
The 52-week low share price for Atea Pharmaceuticals, Inc. (AVIR:NAS) is USD$2.78.
What is the dividend yield for Atea Pharmaceuticals, Inc. (AVIR:NAS)?
Halo FAQ
Atea Pharmaceuticals, Inc. (AVIR:NAS) does not pay a dividend.
What was Atea Pharmaceuticals, Inc. (AVIR:NAS) last dividend payment?
Halo FAQ
Atea Pharmaceuticals, Inc. (AVIR:NAS) does not pay a dividend.
What is the franking level for Atea Pharmaceuticals, Inc. (AVIR:NAS)?
Halo FAQ
Atea Pharmaceuticals, Inc. (AVIR:NAS) has a franking level of 0.00%.
In which sector is Atea Pharmaceuticals, Inc. (AVIR:NAS) classified?
Halo FAQ
Atea Pharmaceuticals, Inc. (AVIR:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial